{"id":2013,"date":"2023-03-09T21:56:10","date_gmt":"2023-03-09T18:56:10","guid":{"rendered":"https:\/\/www.sightsciences.com\/us\/?p=1805"},"modified":"2024-05-28T12:46:17","modified_gmt":"2024-05-28T09:46:17","slug":"sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system","status":"publish","type":"post","link":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/","title":{"rendered":"Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System"},"content":{"rendered":"<div class=\"ndq-section\">\n<div id=\"ndq-content\" class=\"row ndq-7791\">\n<div class=\"column large-12\">\n<div class=\"region region-content\">\n<div class=\"hidden\" data-drupal-messages-fallback=\"\"><\/div>\n<div id=\"block-nir-pid4158-content\" class=\"block--system-main-block block--system-main-block--7791 block--content--system-main-block block--content--system-main-block--7791 block--d3e5cab3-701e-469f-8150-a0c2ef34d4c7 block--d3e5cab3-701e-469f-8150-a0c2ef34d4c7--7791 block block-system block-system-main-block\">\n<article class=\"node node--nir-news--full node--type-nir-news node--view-mode-full node--promoted\">\n<div class=\"file-link pdf-file-link\"><span class=\"file file--mime-application-pdf file--application-pdf\"><a href=\"\/wp-content\/uploads\/2023\/03\/Sight-Sciences-Launches-the-Ergo-Series-of-the-OMNI\u00ae-Surgical-System.pdf\" target=\"_blank\" rel=\"noopener\">PDF Version<\/a><\/span><\/div>\n<p>&nbsp;<\/p>\n<div class=\"node__content\">\n<div class=\"box__wrap\">\n<div class=\"box__right\">\n<div class=\"field field--name-field-nir-news-related-photos field--type-field-collection field--label-hidden\">\n<div class=\"field__items\">\n<div class=\"field__item\">\n<div class=\"supporting_image_wrapper\">\n<div class=\"field field--name-field-related-photos-title field--type-string field--label-hidden field__item\">Ergo-Series of the OMNI\u00ae Surgical System by Sight Sciences, Inc.<\/div>\n<div class=\"supporting_image\"><a href=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8\" target=\"_blank\" rel=\"noopener\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8\" alt=\"Ergo-Series of the OMNI\u00ae Surgical System by Sight Sciences, Inc.\" \/><br \/>\n<\/a><\/div>\n<div class=\"supporting_image_description\">\n<div class=\"clearfix text-formatted field field--name-field-related-photos-caption field--type-text-long field--label-hidden field__item\">\n<p>The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<h3 class=\"subhead-gnw\">The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures<\/h3>\n<p>&nbsp;<\/p>\n<p align=\"left\">MENLO PARK, Calif., March 09, 2023 (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hNnxe5Tk7lptqgRrZI2dkrXHplVi4AH6RzfC2BZX5Zyb0nuaiMr9mXVyghRs6zLFKTMPIP6llJZPtJ480PdGMObbKfDQq63iSHERH8Bnx7D2KhanydAp5xy9vpHvvaoPFSNDLGFskV29A6zwXOWwF1klqha6HkKiWJk3MOj--mEbulPL90bP_uHu2wy1flFGdMSUCgibQjT2Y7yKvJV40wHKd9f4FtpdDgRQ-o1lRs85-1XsiHkTVElX1uUoH5k0XqUJEEoHEESN0fZAT0adrg==\" target=\"_blank\" rel=\"nofollow noopener\">Sight Sciences, Inc.<\/a> (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that provides solutions intended to transform care and improve patients&#8217; lives, today announced the United States launch of the Ergo-Series of the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1Z3EvMGAqp_41tCtT9nrAn9A3ARTK8ZYpE2a7dhinu-sefXqVo-wCediW6lZzAhB4W0BwCxBnwKjOKxsTVfOezAEpxKY2cpNmPXVjBIyPyc=\" target=\"_blank\" rel=\"nofollow noopener\">OMNI\u00ae Surgical System<\/a>, a technology that facilitates surgeons\u2019 ability to perform minimally invasive, implant-free glaucoma procedures in adults with primary open-angle glaucoma.<br class=\"\" \/><br class=\"\" \/><\/p>\n<p>The OMNI Surgical System enables a minimally invasive glaucoma surgery (MIGS) that addresses all three known points of resistance in the aqueous outflow system: the trabecular meshwork, Schlemm\u2019s canal, and the collector channels. It can be used before, in combination with, or following cataract surgery. The new features of the Ergo-Series include:<br \/>\n<br class=\"\" \/><\/p>\n<ul>\n<li><strong>Improved<\/strong><strong> Handle Ergonomics: <\/strong>New enhancements enable surgeons to more easily rotate and position the cannula tip within Schlemm\u2019s canal with precise finger rotations versus wrist adjustments.<\/li>\n<li><strong>Simplified Viscoelastic Preparation:<\/strong> The handle\u2019s viscoelastic luer connector is now removable and detaches when the viscoelastic cartridge is removed, resulting in more clearance with the surgical microscope.<\/li>\n<li><strong>New Cannula Tip Design:<\/strong> The Ergo-Series cannula tip has a new profile that enables gentle and precise access to Schlemm&#8217;s canal while continuing to enable full 360-degree catheterization associated with the OMNI procedure.<br \/>\n<br class=\"\" \/><\/li>\n<\/ul>\n<p>Reay Brown, MD, a Glaucoma Specialist and Sight Science&#8217;s Chief Medical Officer, said &#8220;The Ergo-Series maintains the same therapeutic functionality as the second-generation OMNI Surgical System. The technology enhancements provide additional benefits that enable surgeons to perform an innovative, minimally invasive glaucoma surgery.&#8221;<\/p>\n<p>&nbsp;<\/p>\n<p>\u201cFor me, the new cannula tip technology is the biggest improvement,\u201d said Zarmeena Vendal, MD, glaucoma surgeon and founder of Westlake Eye Specialists in Austin, Texas. \u201cThe profile of the tip enables me to score the trabecular meshwork more confidently and makes entry into Schlemm\u2019s canal gentler. In addition, when I deploy the catheter, I can follow the path of the Schlemm\u2019s canal a bit more naturally. In our glaucoma surgery practice, access to the OMNI Surgical System lets us provide these new technology procedures for the benefit of our patients.\u201d<\/p>\n<p>&nbsp;<\/p>\n<p>OMNI Surgical System, Ergo-Series enables surgeons to provide a minimally invasive, implant-free surgery to reduce intraocular pressure (IOP) in adults with primary open-angle glaucoma. The device\u2019s indications for use, contraindications, warning, and precautions remain unchanged. The OMNI Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm\u2019s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. It can be used before, in combination with, or following cataract surgery.<\/p>\n<p>&nbsp;<\/p>\n<p>Paul Badawi, CEO and co-founder of Sight Sciences, added, \u201cOMNI is an innovative technology developed to enable a surgeon to perform a circumferential and complete outflow procedure that addresses all three known points of resistance in the aqueous outflow system through a single clear corneal incision. We are committed to continually innovating and improving our core technologies alongside our surgeon partners in order to provide the greatest benefit to patients suffering from primary open-angle glaucoma. Based on the initial feedback, we are confident the Ergo-Series of the OMNI Surgical System will continue to raise the bar.\u201d<\/p>\n<p>&nbsp;<\/p>\n<p>The Ergo-Series of the OMNI Surgical System is expected to be available outside the United States later this year.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>About Sight Sciences<\/strong><br \/>\nSight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients\u2019 lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world\u2019s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company\u2019s OMNI<sup>\u00ae<\/sup> Surgical System is a minimally invasive glaucoma surgery (MIGS) device indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma (POAG), the world\u2019s leading cause of irreversible blindness. The SION\u2122 Surgical Instrument is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company\u2019s TearCare<sup>\u00ae<\/sup> System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), enabling office-based clearance of gland obstructions by physicians to address the leading cause of dry eye disease.<\/p>\n<p>&nbsp;<\/p>\n<p>For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9QcAMpwONwUSKkEft9r0ptyjuSDdY15Ud4RGu32P2oPc9MMZJjPSV3uJ9Z5vGt9k8bxINoEFNQjoNex_aBlIhJ7-vg-L4TpMZwG27kyxVCgrD17pjs6If1xYMOHKqUU-jMSV8CMrmDCemR3p95R510wqUu9HB9FXlHy1n_9hyibBwsntqsBVB93XVl0c3EBCr0R4jB2FlkXwegT8oMo6F_ikC9n8xGyq76h2X6tw81ivqipezXipHXgviT7E27_2\" target=\"_blank\" rel=\"nofollow noopener\">SightSciences.com<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>About the OMNI Surgical System<\/strong><br \/>\nThe OMNI<sup>\u00ae<\/sup> Surgical System technology consists of a handheld, single-use therapeutic device for minimally invasive glaucoma surgery (MIGS). OMNI allows surgeons to access 360 degrees and three primary points of resistance of an eye\u2019s diseased conventional outflow pathway (trabecular meshwork, Schlemm\u2019s canal, and collector channels) through a single clear corneal microincision.<\/p>\n<p>&nbsp;<\/p>\n<p>OMNI&#8217;s FDA-cleared indication is for canaloplasty (the microcatheterization and viscodilation of Schlemm\u2019s canal) followed by trabeculotomy (the cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. OMNI has a CE Mark for the catheterization and transluminal viscodilation of Schlemm\u2019s canal and the cutting of trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma.<\/p>\n<p>&nbsp;<\/p>\n<p>OMNI should not be used in any situations where the iridocorneal angle is compromised or has been damaged since it may not be possible to visualize the angle or to properly pass the microcatheter. Do not use the OMNI in patients with angle recession; neovascular glaucoma; chronic angle closure; narrow-angle glaucoma; traumatic or malignant glaucoma; or narrow inlet canals with plateau iris or in quadrants with previous MIGS implants.<\/p>\n<p>&nbsp;<\/p>\n<p>OMNI technology is protected by a global patent portfolio including 32 issued patents worldwide.<\/p>\n<p>&nbsp;<\/p>\n<p>For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DpDlDWm04JZUHWHY0r92ZVLPJtB8YBoe2jlI73AUUQGXNRwumDVHfSoO0uLa9sh6jBpD4ZOYnhec713tHP7o22W2s_K2NrCByIWiCeHzjBs=\" target=\"_blank\" rel=\"nofollow noopener\">www.OMNIsurgical.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Forward-Looking Statements<\/strong><br \/>\nThis press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Any statements made in this press release or during the earnings call that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;suggests,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;estimates,&#8221; &#8220;targets,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;forecast&#8221; and other similar expressions. We base these forward-looking statements on our current expectations, plans and assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances at such time. Although we believe that these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our business, results of operations and financial condition and could cause actual results to differ materially from those expressed in the forward-looking statements. These statements are not guarantees of future performance or results. The forward-looking statements are subject to and involve risks, uncertainties and assumptions, and you should not place undue reliance on these forward-looking statements. These forward-looking statements include, but are not limited to, statements concerning the following: estimates of our total addressable market, future revenue, expenses, capital requirements, and our needs for additional financing; our ability to enter into and compete in new markets; execution of our market strategies; the impact of the COVID-19 pandemic on our business, our customers&#8217; and suppliers&#8217; businesses and the general economy; our ability to compete effectively with existing competitors and new market entrants; our ability to scale our infrastructure; our ability to manage and grow our business by expanding our sales to existing customers or introducing our products to new customers; our ability to establish and maintain intellectual property protection for our products or avoid claims of infringement; potential effects of extensive government regulation; our abilities to obtain and maintain regulatory approvals and clearances for our products that support our revenue projections, business strategies and growth; our ability to successfully execute our clinical trial roadmap; our ability to obtain and maintain sufficient reimbursement for our products; our abilities to protect and scale our intellectual property portfolio; our ability to hire and retain key personnel; our ability to obtain financing in future offerings; the volatility of the trading price of our common stock; our expectation regarding the time during which we will be an emerging growth company under the Jumpstart Our Business Startups Act (the &#8220;JOBS Act&#8221;); our ability to maintain proper and effective internal controls; and the other important factors discussed under the caption &#8220;Risk Factors&#8221; in our filings with the U.S. Securities and Exchange Commission, as may be updated from time to time in subsequent filings. These cautionary statements should not be construed by you to be exhaustive and are made only as of the date of this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Media contact<\/strong><br \/>\nCarmen Caricchio<br \/>\nC2M Group<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sDhjVpQJpprXhssQgwqUxfYG6knFY5xad7qBv3yVrzRjNhI_Tynz3mE_i2emSXtBo_v_8Emq6O5o_K6YX8BYghvK6ITu__oVgcIOWYTMfqw=\" target=\"_blank\" rel=\"nofollow noopener\">pr@SightSciences.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Investor contact<\/strong><br \/>\nPhilip Taylor<br \/>\nGilmartin Group<br \/>\n415.937.5406<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-FmyoLqXeiQ5FMdWPfcmDgcQcZbqgozPs_o-T_SXOF5KsW3xzP89wyoXhvTDvuiirJccgJVcqkU6_aKR8KwEGfuoFX-KWxeftAMwdCyRrSwePJJPkMA2n9NxTapHrffRnvaKDmUFZC__IutTaNhjOA==\" target=\"_blank\" rel=\"nofollow noopener\">Investor.Relations@Sightsciences.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>\u00a9 2023 Sight Sciences. All rights reserved. Dr. Vendal is a paid consultant of Sight Sciences. OMNI and SION are trademarks or registered trademarks of Sight Sciences. 02\/2023 OM-2790-US.v1<\/p>\n<p>&nbsp;<\/p>\n<p>A photo accompanying this announcement is available at:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VbFu3xZNWKiT5vg2-mgqNZgZCsZrgMtsZl0um36TVKd_7Wojaa-0c7cJ79eblnvYmFe6JuBRNUbG0BFsM9VCZWAHn5-q0Rn1SVz-65WtzEo3rkBaG30x_c85Pm3HWmxyVWC0R3gf3s6RoelURgJy-d42sMOJSMDf-eXSmkDIixnYlLuM1vjIBSWrozqz3bPqLpya72_-kGlAjgb3qjoolREgX44fC5ttVVd5Ttd5cC1ZoIbcpobiTgT3i_hNK0t5FMJJp-jXi3LvvLpQRzOvOQ==\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MDVmM2Q3NGQtYTMwOC00MGEyLThlZDctN2FkNTlkMDYwMjBlLTEyMjEzMjQ=\/tiny\/Sight-Sciences-Inc-.png\" alt=\"\" \/><\/p>\n<\/div>\n<\/article>\n<\/div>\n<div id=\"block-nir-pid4158-websitenoticeblock\" class=\"block--website-notice-block block--website-notice-block--7791 block--content--website-notice-block block--content--website-notice-block--7791 block--4d7a5f5e-26bd-48f8-9ae6-c5112267a7f5 block--4d7a5f5e-26bd-48f8-9ae6-c5112267a7f5--7791 block block-nir-website-notices block-website-notice-block\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PDF Version &nbsp; Ergo-Series of the OMNI\u00ae Surgical System by Sight Sciences, Inc. The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures &nbsp; The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures &nbsp; MENLO PARK, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6,5],"tags":[],"class_list":["post-2013","post","type-post","status-publish","format-standard","hentry","category-news","category-omni"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System - United States<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System\" \/>\n<meta property=\"og:description\" content=\"PDF Version &nbsp; Ergo-Series of the OMNI\u00ae Surgical System by Sight Sciences, Inc. The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures &nbsp; The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures &nbsp; MENLO PARK, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-09T18:56:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-28T09:46:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8\" \/>\n<meta name=\"author\" content=\"admin-dev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin-dev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/\"},\"author\":{\"name\":\"admin-dev\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091\"},\"headline\":\"Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System\",\"datePublished\":\"2023-03-09T18:56:10+00:00\",\"dateModified\":\"2024-05-28T09:46:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/\"},\"wordCount\":1696,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8\",\"articleSection\":[\"News\",\"OMNI\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/\",\"url\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/\",\"name\":\"Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System - United States\",\"isPartOf\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8\",\"datePublished\":\"2023-03-09T18:56:10+00:00\",\"dateModified\":\"2024-05-28T09:46:17+00:00\",\"author\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#primaryimage\",\"url\":\"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8\",\"contentUrl\":\"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sightsciences.com\/us\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/#website\",\"url\":\"https:\/\/www.sightsciences.com\/us\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sightsciences.com\/us\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091\",\"name\":\"admin-dev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g\",\"caption\":\"admin-dev\"},\"url\":\"https:\/\/www.sightsciences.com\/us\/author\/admin-dev\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System - United States","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/","og_locale":"en_US","og_type":"article","og_title":"Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System","og_description":"PDF Version &nbsp; Ergo-Series of the OMNI\u00ae Surgical System by Sight Sciences, Inc. The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures &nbsp; The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures &nbsp; MENLO PARK, [&hellip;]","og_url":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/","og_site_name":"United States","article_published_time":"2023-03-09T18:56:10+00:00","article_modified_time":"2024-05-28T09:46:17+00:00","og_image":[{"url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8","type":"","width":"","height":""}],"author":"admin-dev","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin-dev","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#article","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/"},"author":{"name":"admin-dev","@id":"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091"},"headline":"Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System","datePublished":"2023-03-09T18:56:10+00:00","dateModified":"2024-05-28T09:46:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/"},"wordCount":1696,"commentCount":0,"image":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#primaryimage"},"thumbnailUrl":"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8","articleSection":["News","OMNI"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/","url":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/","name":"Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System - United States","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/us\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#primaryimage"},"image":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#primaryimage"},"thumbnailUrl":"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8","datePublished":"2023-03-09T18:56:10+00:00","dateModified":"2024-05-28T09:46:17+00:00","author":{"@id":"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091"},"breadcrumb":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#primaryimage","url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8","contentUrl":"https:\/\/ml.globenewswire.com\/Resource\/Download\/e92fa807-7dd5-42eb-ad76-fa99fb1a9ab8"},{"@type":"BreadcrumbList","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sightsciences.com\/us\/"},{"@type":"ListItem","position":2,"name":"Sight Sciences Launches the Ergo-Series of the OMNI\u00ae Surgical System"}]},{"@type":"WebSite","@id":"https:\/\/www.sightsciences.com\/us\/#website","url":"https:\/\/www.sightsciences.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sightsciences.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091","name":"admin-dev","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g","caption":"admin-dev"},"url":"https:\/\/www.sightsciences.com\/us\/author\/admin-dev\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/posts\/2013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/comments?post=2013"}],"version-history":[{"count":0,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/posts\/2013\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/media?parent=2013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/categories?post=2013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/tags?post=2013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}